Harvoni for chronic hepatitis CFirst once-daily single-tablet regimen for chronic HCV genotype 1 infection. Drug News - February 2014A review of launches, new indications, Health Canada advisories and discontinued products. Drug News - December 2013 Tivicay – second single-entity integrase inhibitor now available for HIV Can be taken once daily without regard to food. Hep C options expand Drug News: February/March 2013 Stribild: new once-daily single-tablet regimen for HIV Drug is the first marketed HIV combination product to contain an integrase inhibitor (elvitegravir) and a new pharmacokinetic enhancer (cobicistat). Politics should have no place in HIV research From its very beginnings, AIDS has been a particularly political illness—and that apparently continues to this day. Drug News: November 2010 New vaccine cuts risk of shingles by half First Previous 2 3 4 Next Last
